Documentary record · CONSULTATION CLOSED
Health Canada’s consultations on the Ministerial Reliance Order guidance and the domestic-manufacturing generic pilot close
COMMENT PERIOD CLOSED
Event date
September 12, 2026
Jurisdiction
Canada
Issuing body
Health Canada
Action type
CONSULTATION CLOSED
Lifecycle state
COMMENT PERIOD CLOSED
Verification date
15 September 2026
Legal effect
Two comment periods ended on 12 September 2026. Closing a consultation changes no requirement; it ends the opportunity to comment.
What this establishes
- Both consultations ran from 15 July to 12 September 2026.
- The Ministerial Reliance Order, announced 15 July 2026, lets Health Canada use decisions or documents from select foreign regulators to review certain parts of submissions faster; the first classes accepted are drugs for pediatric use and veterinary drugs.
- A separate consultation proposed prioritizing certain generic submissions that involve Canadian manufacturing.
What this does not establish
- A new approval standard; Health Canada states safety, efficacy and quality requirements are maintained.
- The final form of either proposal.
Why it matters
Reliance on trusted foreign reviewers is how a capacity-limited regulator changes speed without changing the bar. Pediatric drugs are the first test.
Primary source
Related on this site
- When submission volume exceeds review capacity
- Drug regulatory capacity dossier
- Earlier record: domestic-manufacturing consultation opened
Register: the record store · record id canada-reliance-consultations-closed-2026-09-12.